Conmed (CNMD) Asset Writedowns and Impairment (2021)
Conmed (CNMD) reported Asset Writedowns and Impairment of $899000.0 for Q3 2021.
Conmed (CNMD) Asset Writedowns and Impairment (2021) Analysis & Trends
Conmed has reported Asset Writedowns and Impairment for 1 years, with the latest figure at $899000.0 in Q3 2021.
- For the quarter ending Q3 2021, Asset Writedowns and Impairment changed N/A year-over-year to $899000.0; the trailing twelve-month figure through Dec 2022 stood at $899000.0 (changed N/A YoY), and the FY2025 full-year result was $363000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q3 2021 stood at $899000.0.
- The five-year high for Asset Writedowns and Impairment was $899000.0 in Q3 2021, with the low at $899000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Conmed | 994.72 Mn | 959.69 Mn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 899,000.00 |
| Sep 30, 2021 | 899,000.00 |